Cranswick (LON:CWK) Posts Quarterly Earnings Results
by Teresa Graham · The Cerbat GemCranswick (LON:CWK – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported GBX 301.70 earnings per share for the quarter, Digital Look Earnings reports. The company had revenue of GBX 298.25 billion during the quarter. Cranswick had a net margin of 5.31% and a return on equity of 14.99%.
Here are the key takeaways from Cranswick’s conference call:
- The company reported a strong FY2026, with revenue up 9.5%, adjusted profit before tax up 11.2%, and adjusted EPS up 10.4%, all driven by continued volume growth.
- Adjusted operating margin improved to 7.9%, supported by capacity utilization, automation, poultry farming performance, and tight cost control. Management also highlighted record free cash flow of GBP 268.4 million.
- The board proposed a 12.5% increase in the final dividend, extending the company’s record of 36 consecutive years of dividend growth. The full-year dividend rose 11.4%.
- Cranswick announced a GBP 56 million investment to expand its Eye poultry facility, lifting capacity by 25% by summer 2027. The company said the site will eventually process more than double the birds originally planned in 2019.
- Commercial momentum remained broad-based, with poultry revenue up 13.9%, gourmet revenue up 15.3%, and pet products revenue up 29.8%, while management noted a volatile input-cost backdrop and ongoing inflation pressure.
Cranswick Trading Up 0.5%
Shares of CWK stock opened at GBX 5,490 on Thursday. Cranswick has a 12-month low of GBX 4,805 and a 12-month high of GBX 5,620. The company has a current ratio of 1.76, a quick ratio of 1.02 and a debt-to-equity ratio of 23.60. The firm’s 50 day moving average is GBX 5,272.15 and its 200 day moving average is GBX 5,163.48. The stock has a market capitalization of £2.94 billion, a P/E ratio of 20.29, a P/E/G ratio of 2.62 and a beta of 0.56.
Insider Buying and Selling at Cranswick
In other news, insider Adam Couch sold 347 shares of the business’s stock in a transaction on Monday, March 23rd. The shares were sold at an average price of GBX 507, for a total transaction of £1,759.29. Also, insider Mark Bottomley sold 250 shares of the company’s stock in a transaction on Tuesday, March 24th. The stock was sold at an average price of GBX 5,097, for a total value of £12,742.50. In the last quarter, insiders have bought 8 shares of company stock worth $42,490 and have sold 707 shares worth $2,010,739. Company insiders own 2.54% of the company’s stock.
Wall Street Analyst Weigh In
Several equities research analysts recently issued reports on the stock. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a GBX 6,100 target price on shares of Cranswick in a report on Wednesday. Berenberg Bank restated a “hold” rating and issued a GBX 5,770 target price on shares of Cranswick in a report on Tuesday, January 27th. Jefferies Financial Group restated a “buy” rating and issued a GBX 62 target price on shares of Cranswick in a report on Wednesday. Finally, Shore Capital Group restated a “house stock” rating on shares of Cranswick in a report on Tuesday. Three analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of GBX 4,358.
View Our Latest Report on Cranswick
About Cranswick
Cranswick is a leading and innovative supplier of premium, fresh and added-value food products with revenues of more than £2.7 billion. The business employs over 15,400 people and operates from 23 well-invested, highly efficient facilities in the UK. Cranswick was formed in the early 1970s by farmers in East Yorkshire to produce animal feed and has since evolved into a business which produces a range of high-quality, predominantly fresh food, including fresh pork, poultry, convenience, gourmet products and pet food.
Featured Stories
- Five stocks we like better than Cranswick
- Freight Boom: The Hormuz Blockade Payday
- The Palantir Paradox—Record Numbers and a Stock That Won’t Cooperate
- TJX Companies Fires on All Cylinders With 9% Revenue Growth
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook